A real-world comparison of in-person vs. virtual contraceptive care trainings for clinicians and support staff

被引:1
|
作者
LeRoy, Lisa [1 ]
West, Adam M. [1 ]
Hall, Calvin [1 ]
Thomas, Danielle [1 ]
Braun, Stephen [2 ]
机构
[1] Upstream USA, Boston, MA 02109 USA
[2] Freelance Med Writer, Amherst, MA USA
关键词
Cliniciantraining; Contraceptivecare; Contraceptivetraining; In-persontraining; Upstream; Virtualtraining;
D O I
10.1016/j.contraception.2022.03.019
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To conduct an exploratory analysis comparing in-person vs. virtual training programs about contraceptive care among clinicians and staff at 14 healthcare agencies in Washington state.Methods: Survey data from in-person trainings were collected between July 2019 and March 2020 and from virtual trainings between June 2020 and January 2021. Primary outcomes: changes in contraceptive knowledge, understanding of contraceptive counseling and care, and participant engagement and experi-ence with the training.Results: Post-survey response rates for in-person trainings were 82% for clinicians and 72% for support staff while post-survey response rates for virtual trainings were 48% for clinicians and 43% for staff. Aver-age knowledge scores for in-person clinician trainings increased from 63% prior to training to 80% post -training ( p < 0.05), knowledge scores for virtual clinician trainings increased from 72% to 86% ( p < 0.05), and the pre-to-post change in scores between training modalities was similar ( p > 0.05 for the score dif-ference). Average knowledge scores among in-person support staff trainings increased from 63% to 84% ( p < 0.05), scores among virtual support staff trainings increased from 68% to 87% ( p < 0.05) and, again, the pre-to-post change in scores between training modalities was similar ( p > 0.05 for the score differ-ence). Only minimal differences in survey scores between modalities were observed on most measures of participant engagement and experience with the trainings ( p > 0.05 for most score differences).Conclusions: These exploratory results suggest that in-person and virtual contraceptive care trainings yielded comparable results among both clinicians and support staff.Implications: Results from this post-hoc analysis of survey data suggest a general equivalency of effec-tiveness between in-person trainings and virtual trainings, although in-person trainings may be more satisfying or engaging for participants. Further work and research is needed to inform strategies for mak-ing virtual trainings more engaging and satisfying for participants.(c) 2022 Upstream USA. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页码:74 / 80
页数:7
相关论文
共 50 条
  • [41] Aflibercept (AFL) vs. ramucirumab (RAM) -based therapy in patients with advanced colorectal cancer: Efficacy comparison using real-world data evidence from TriNetX platform
    Rodriguez-Pascual, Jesus
    Hernandez, Gema
    Ugidos, Lisardo
    Parralejo, Alejandro
    Rodriguez-Castano, Juan Diego
    Serrano, Juan Jose
    Ayuso, Angel
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 71 - 71
  • [42] Real-world clinical and economic outcomes in patients with type 2 diabetes initiating glargine disposable pen vs. insulin detemir disposable pen in a US managed care setting
    Xie, L.
    Wei, W.
    Pan, C.
    Du, J.
    Baser, O.
    DIABETOLOGIA, 2011, 54 : S415 - S415
  • [43] Real-world comparison: Neoadjuvant pembrolizumab (pembro-NACT) vs. dose-dense neoadjuvant chemotherapy (ddNACT) in early stage triple-negative breast cancer (TNBC)
    Barbi, Mali
    Noel, Jovanka
    Lee, Chung-Shien
    Rahman, Husneara
    Cheng, Kit
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] Comparison of in-hospital outcomes and readmissions for valve-in-valve transcatheter aortic valve replacement vs. reoperative surgical aortic valve replacement: a contemporary assessment of real-world outcomes
    Hirji, Sameer A.
    Percy, Edward D.
    Zogg, Cheryl K.
    Malarczyk, Alexandra
    Harloff, Morgan T.
    Yazdchi, Farhang
    Kaneko, Tsuyoshi
    EUROPEAN HEART JOURNAL, 2020, 41 (29) : 2747 - 2755
  • [45] A propensity score matched comparison of blood pressure lowering in essential hypertension patients treated with antihypertensive Chinese herbal Medicine: comparing the real-world registry data vs. randomized controlled trial
    Lai, Xinxing
    Fang, Zhenghao
    Dong, Zhenyu
    Wu, Shengxian
    Zhou, Xiaohua
    Gao, Ying
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2023, 45 (01)
  • [46] Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy
    Ingrasciotta, Ylenia
    Fontana, Andrea
    Mancuso, Anna
    Ientile, Valentina
    Sultana, Janet
    Uomo, Ilaria
    Pastorello, Maurizio
    Calabro, Paolo
    Ando, Giuseppe
    Trifiro, Gianluca
    PHARMACEUTICALS, 2021, 14 (04)
  • [47] Treatment comparison of amivantamab vs. real-world therapies among patients with NSCLC harboring EGFR Exon 20 insertion mutations: An external control analysis (ECA) using NTUH NSCLC dataset in Taiwan
    Wu, J-y.
    Zhuo, J.
    Chen, E.
    Wang, S-p.
    Hsieh, J-f.
    Shih, J-y.
    ANNALS OF ONCOLOGY, 2024, 35
  • [48] Comparison of risk assessment in primary ER+, HER2-Breast Cancer in a real-world data set: Classical pathological parameters vs. 12-gene molecular assay (EndoPredict)
    Jank, Paul
    Denkert, Carsten
    Lindner, Judith L.
    Lehmann, Annika
    Pfitzner, Berit M.
    Blohmer, Jens-Uwe
    Horst, David
    Kronenwett, Ralf
    Schmitt, Wolfgang D.
    CANCER RESEARCH, 2021, 81 (04)
  • [49] Real-World Comparison of Healthcare Costs of Venetoclax-Obinutuzumab Vs. Btki Use Among Elderly US Medicare Beneficiaries with Chronic Lymphocytic Leukemia in the Front-Line (1L) Setting
    Manzoor, Beenish S.
    Huntington, Scott F.
    Jawaid, Dureshahwar
    Puckett, Justin T.
    Emechebe, Nnadozie
    Ravelo, Arliene
    Kamal-Bahl, Sachin
    Doshi, Jalpa A.
    BLOOD, 2023, 142
  • [50] Real-world propensity score comparison of treatment effectiveness of peginterferon beta-1a vs. subcutaneous interferon beta-1a, glatiramer acetate, and teriflunomide in patients with relapsing-remitting multiple sclerosis
    Reder, Anthony T.
    Arndt, Nancy
    Roman, Cortnee
    Geremakis, Caroline
    Mendoza, Jason P.
    Su, Ray
    Makin, Charles
    Avila, Robin L.
    Vignos, Megan C.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 51